Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.051
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Characteristics of Pediatric Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Descriptive Evalaution of Characteristics of Patients Diagnosed With Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Disease-Modifying Agents in Progressive Multiple Sclerosis: Management of 100 Patients at Louis Stokes Cleveland VAMC, Spinal Cord Injury Division

Journal of Rehabilitation Research and Development
Rehabilitation
2011English

Real-World Cost of Treatment for Multiple Sclerosis Patients Initiating and Receiving Infused Disease-Modifying Therapies Per Recommended Label in the United States

Journal of Medical Economics
Health Policy
2020English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the US

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy